Genetics Generation Advancement Corp. (TPEX:4160)

Market Cap	1.33B -26.8%
Revenue (ttm)	589.13M -11.3%
Net Income	13.36M -77.2%
EPS	0.49 -77.4%
Shares Out	26.69M
PE Ratio	101.51
Forward PE	n/a
Dividend	1.85 (3.70%)
Ex-Dividend Date	Oct 3, 2025

Volume	43,048
Average Volume	80,496
Open	49.90
Previous Close	50.20
Day's Range	49.85 - 50.80
52-Week Range	46.90 - 74.00
Beta	0.45
RSI	40.29
Earnings Date	Mar 26, 2026

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4160

Financial Performance

In 2024, TPEX:4160's revenue was 661.86 million, an increase of 11.71% compared to the previous year's 592.50 million. Earnings were 54.70 million, an increase of 91.49%.